BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 15010275)

  • 21. Effects of prostacyclin analogs on the synthesis of tissue factor, tumor necrosis factor-alpha and interleukin-1 beta in human monocytic THP-1 cells.
    Crutchley DJ; Conanan LB; Que BG
    J Pharmacol Exp Ther; 1994 Oct; 271(1):446-51. PubMed ID: 7525928
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Platelet receptor desensitization induced by elevated prostacyclin levels causes platelet-endothelial cell adhesion.
    Darius H; Binz C; Veit K; Fisch A; Meyer J
    J Am Coll Cardiol; 1995 Sep; 26(3):800-6. PubMed ID: 7543911
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CEP-7055: a novel, orally active pan inhibitor of vascular endothelial growth factor receptor tyrosine kinases with potent antiangiogenic activity and antitumor efficacy in preclinical models.
    Ruggeri B; Singh J; Gingrich D; Angeles T; Albom M; Yang S; Chang H; Robinson C; Hunter K; Dobrzanski P; Jones-Bolin S; Pritchard S; Aimone L; Klein-Szanto A; Herbert JM; Bono F; Schaeffer P; Casellas P; Bourie B; Pili R; Isaacs J; Ator M; Hudkins R; Vaught J; Mallamo J; Dionne C
    Cancer Res; 2003 Sep; 63(18):5978-91. PubMed ID: 14522925
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Activation of gene transcription by prostacyclin analogues is mediated by the peroxisome-proliferators-activated receptor (PPAR).
    Hertz R; Berman I; Keppler D; Bar-Tana J
    Eur J Biochem; 1996 Jan; 235(1-2):242-7. PubMed ID: 8631336
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Activation of toll-like receptor 4 modulates vascular endothelial growth factor synthesis through prostacyclin-IP signaling.
    Park DW; Baek K; Lee JG; Park YK; Kim JH; Kim JR; Baek SH
    Biochem Biophys Res Commun; 2007 Nov; 362(4):1090-5. PubMed ID: 17825254
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A novel vascular endothelial growth factor encoded by Orf virus, VEGF-E, mediates angiogenesis via signalling through VEGFR-2 (KDR) but not VEGFR-1 (Flt-1) receptor tyrosine kinases.
    Meyer M; Clauss M; Lepple-Wienhues A; Waltenberger J; Augustin HG; Ziche M; Lanz C; Büttner M; Rziha HJ; Dehio C
    EMBO J; 1999 Jan; 18(2):363-74. PubMed ID: 9889193
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Flt-1 intraceptors inhibit hypoxia-induced VEGF expression in vitro and corneal neovascularization in vivo.
    Singh N; Amin S; Richter E; Rashid S; Scoglietti V; Jani PD; Wang J; Kaur R; Ambati J; Dong Z; Ambati BK
    Invest Ophthalmol Vis Sci; 2005 May; 46(5):1647-52. PubMed ID: 15851564
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hypoxia regulates vascular endothelial growth factor receptor KDR/Flk gene expression through adenosine A2 receptors in retinal capillary endothelial cells.
    Takagi H; King GL; Ferrara N; Aiello LP
    Invest Ophthalmol Vis Sci; 1996 Jun; 37(7):1311-21. PubMed ID: 8641834
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Activation of fractalkine/CX3CR1 by vascular endothelial cells induces angiogenesis through VEGF-A/KDR and reverses hindlimb ischaemia.
    Ryu J; Lee CW; Hong KH; Shin JA; Lim SH; Park CS; Shim J; Nam KB; Choi KJ; Kim YH; Han KH
    Cardiovasc Res; 2008 May; 78(2):333-40. PubMed ID: 18006432
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HGF/NK4 inhibited VEGF-induced angiogenesis in in vitro cultured endothelial cells and in vivo rabbit model.
    Nakabayashi M; Morishita R; Nakagami H; Kuba K; Matsumoto K; Nakamura T; Tano Y; Kaneda Y
    Diabetologia; 2003 Jan; 46(1):115-23. PubMed ID: 12637990
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differential regulation of early growth response gene-1 expression by insulin and glucose in vascular endothelial cells.
    Hasan RN; Phukan S; Harada S
    Arterioscler Thromb Vasc Biol; 2003 Jun; 23(6):988-93. PubMed ID: 12689920
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Coordinate expression of vascular endothelial growth factor receptor-1 (flt-1) and its ligand suggests a paracrine regulation of murine vascular development.
    Breier G; Clauss M; Risau W
    Dev Dyn; 1995 Nov; 204(3):228-39. PubMed ID: 8573716
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interleukin-1alpha promotes angiogenesis in vivo via VEGFR-2 pathway by inducing inflammatory cell VEGF synthesis and secretion.
    Salven P; Hattori K; Heissig B; Rafii S
    FASEB J; 2002 Sep; 16(11):1471-3. PubMed ID: 12205052
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Age-dependent modifications of expression level of VEGF and its receptors in the inner ear.
    Picciotti P; Torsello A; Wolf FI; Paludetti G; Gaetani E; Pola R
    Exp Gerontol; 2004 Aug; 39(8):1253-8. PubMed ID: 15288700
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Iloprost up-regulates vascular endothelial growth factor expression in human dental pulp cells in vitro and enhances pulpal blood flow in vivo.
    Limjeerajarus CN; Osathanon T; Manokawinchoke J; Pavasant P
    J Endod; 2014 Jul; 40(7):925-30. PubMed ID: 24935537
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of prostaglandin I2 analogs on macrophage inflammatory protein 1α in human monocytes via I prostanoid receptor and cyclic adenosine monophosphate.
    Tsai MK; Hsieh CC; Kuo HF; Yang SN; Kuo CH; Huang MY; Tsai YM; Lee MS; Hung CH
    J Investig Med; 2014 Feb; 62(2):332-9. PubMed ID: 24402297
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of prostacyclin receptors in luteinizing hormone-releasing hormone immortalized neurons: role in the control of hormone secretion.
    Pimpinelli F; Rovati GE; Capra V; Piva F; Martini L; Maggi R
    Endocrinology; 1999 Jan; 140(1):171-7. PubMed ID: 9886823
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of TPA and 12(S)-HETE-stimulated tumor cell adhesion by prostacyclin and its stable analogs: rationale for their antimetastatic effects.
    Tang DG; Grossi IM; Tang KQ; Diglio CA; Honn KV
    Int J Cancer; 1995 Jan; 60(3):418-25. PubMed ID: 7530235
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Targeting the Prostacyclin Pathway: Beyond Pulmonary Arterial Hypertension.
    Pluchart H; Khouri C; Blaise S; Roustit M; Cracowski JL
    Trends Pharmacol Sci; 2017 Jun; 38(6):512-523. PubMed ID: 28412042
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of Iloprost, Cicaprost and prostacyclin effects on cyclic AMP metabolism in intact platelets.
    Ashby B
    Prostaglandins; 1992 Mar; 43(3):255-61. PubMed ID: 1378640
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.